找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Chemotherapy and Urological Malignancy; A. S. D. Spiers (Professor of Medicine) Book 1982 Springer-Verlag Berlin Heidelberg 1982 Urogenita

[復(fù)制鏈接]
樓主: 退縮
21#
發(fā)表于 2025-3-25 04:47:27 | 只看該作者
Chemotherapy of Cancer of the Prostate,he expected annual incidence is 42000 new cases with 17000 deaths. It has been estimated that 30% of cases are potentially curable when first discovered but this is open to serious question (Klein 1979). Between 1950 and 1970 the reported incidence of prostatic carcinoma rose from 17 to 21 per 10000
22#
發(fā)表于 2025-3-25 09:48:12 | 只看該作者
23#
發(fā)表于 2025-3-25 13:44:20 | 只看該作者
,Urological Oncology — A European View,ontinuing financial support from the National Cancer Institute (NCI) in Bethesda. It has also been aided in the last 5 years by private donations collected by the EORTC foundation and, since 1979, has had official support from the European Community.
24#
發(fā)表于 2025-3-25 15:55:56 | 只看該作者
25#
發(fā)表于 2025-3-25 23:50:27 | 只看該作者
Chemotherapy and Urological Malignancy978-1-4471-1332-4Series ISSN 0177-8994
26#
發(fā)表于 2025-3-26 01:46:23 | 只看該作者
Quick Guide to the Management of Keratoconusontinuing financial support from the National Cancer Institute (NCI) in Bethesda. It has also been aided in the last 5 years by private donations collected by the EORTC foundation and, since 1979, has had official support from the European Community.
27#
發(fā)表于 2025-3-26 04:46:45 | 只看該作者
https://doi.org/10.1007/978-1-4471-1332-4Urogenitalkrebs; Zytostatikum; cancer; carcinoma; chemotherapy; kidney; prostate; tumor
28#
發(fā)表于 2025-3-26 10:50:05 | 只看該作者
29#
發(fā)表于 2025-3-26 15:42:54 | 只看該作者
Dynamic Asset Allocation with Credit Riskence of this tumor is only 0.2/100,000. However, the propensity for adrenal cortical carcinoma to excrete hormones has led to unique groups of drugs which produce significant palliation of bothersome and life-threatening endocrinologically induced symptoms. Cushing’s syndrome, virilization, feminiza
30#
發(fā)表于 2025-3-26 20:20:08 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 12:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
营山县| 古浪县| 陆丰市| 太仓市| 三河市| 祁连县| 崇礼县| 景宁| 应用必备| 冷水江市| 平乐县| 宣城市| 瓦房店市| 辉南县| 长岭县| 来宾市| 桦甸市| 巫溪县| 灵石县| 都匀市| 阜平县| 马尔康县| 金溪县| 碌曲县| 九江市| 同德县| 罗田县| 金塔县| 萍乡市| 临漳县| 建水县| 沙田区| 平定县| 南城县| 济宁市| 攀枝花市| 布尔津县| 奇台县| 平舆县| 淮滨县| 涟源市|